“…On the other hand, in a more recent study, Phillips et al (27), using a higher number of patients, reported a strong expression of IFN-g in both nodular and ulcerative lesions. Also in line with our findings, supporting therefore the existence of protective cellular-mediated immune and delayed-type hypersensitivity responses, associated with IFN-g production in the context of Th1 responses, when BU disease progresses to healing, granuloma formation occurs (3,46,(53)(54)(55), and the positivity of the Burulin skin test increases (56)(57)(58). In addition, BCG vaccination was found to protect humans against BU osteomyelitis (59), and BCG or a DNA vaccine encoding Ag85A from BCG confer some degree of protection against M. ulcerans experimental infections (60,61).…”